Evaluation of Patients with Synchronous Bilateral Breast Cancer

Objective: Breast cancer is the most common cancer in women. The incidence of bilateral breast cancer is 2%–11%. Synchronous bilateral breast cancer is uncommon (1%–2%). Bilateral breast cancer has worse prognosis than unilateral cancer. The aim of the retrospective study was to evaluate the inciden...

Full description

Bibliographic Details
Main Authors: Elif Eda Tiken, Meral Günaldı, Yıldız Okuturlar, Savaş Tuna
Format: Article
Language:English
Published: Galenos Yayinevi 2015-06-01
Series:İstanbul Medical Journal
Subjects:
Online Access: http://imj.galenos.com.tr/archives/archive-detail/article-preview/evaluation-of-patients-with-synchronous-bilateral-/20972
_version_ 1797906240479690752
author Elif Eda Tiken
Meral Günaldı
Yıldız Okuturlar
Savaş Tuna
author_facet Elif Eda Tiken
Meral Günaldı
Yıldız Okuturlar
Savaş Tuna
author_sort Elif Eda Tiken
collection DOAJ
description Objective: Breast cancer is the most common cancer in women. The incidence of bilateral breast cancer is 2%–11%. Synchronous bilateral breast cancer is uncommon (1%–2%). Bilateral breast cancer has worse prognosis than unilateral cancer. The aim of the retrospective study was to evaluate the incidence and demographic features of synchronous bilateral breast cancer patients in our hospital.Methods: We analyzed 266 breast cancer patients who were treated at our oncology department between January 2010 and December 2013. Five patients had synchronous bilateral breast cancer that was diagnosed at the same time.Results: We determined that five (1.87%) patients had synchronous bilateral breast cancer in this study. Of the five patients, one was a man and four were women. Median age was 53 years (40–64). Two patients were in premenopausal status. One patient revealed a positive family history of first-degree relatives. All of the patients had estrogen receptor positivity and invasive ductal carcinoma histopathology. Neoadjuvant chemotherapy was given to four patients. Only one metastatic patient had palliative chemotherapy. All patients had modified radical mastectomies and postoperative radiation therapy for bilateral breast cancer.Conclusion: Our clinical findings show a correlation with literature knowledge. Synchronous bilateral breast cancer is uncommon, and published data indicates worse prognosis. Hence, patients should be evaluated for the risk of contralateral breast cancer carefully at the same time of diagnosis.
first_indexed 2024-04-10T10:17:49Z
format Article
id doaj.art-66c3f97119464cc693d9092b6bc3b690
institution Directory Open Access Journal
issn 2619-9793
2148-094X
language English
last_indexed 2024-04-10T10:17:49Z
publishDate 2015-06-01
publisher Galenos Yayinevi
record_format Article
series İstanbul Medical Journal
spelling doaj.art-66c3f97119464cc693d9092b6bc3b6902023-02-15T16:21:47ZengGalenos Yayineviİstanbul Medical Journal2619-97932148-094X2015-06-01162454710.5152/imj.2015.8554713049054Evaluation of Patients with Synchronous Bilateral Breast CancerElif Eda Tiken0Meral Günaldı1Yıldız Okuturlar2Savaş Tuna3 Bakırköy Dr. Sadi Konuk Eğitim Araştırma Hastanesi, Radyasyon Onkolojisi Bilim Dalı, İstanbul, Türkiye Bakırköy Dr. Sadi Konuk Eğitim Araştırma Hastanesi, Tıbbi Onkoloji Bilim Dalı, İstanbul, Türkiye Bakırköy Dr. Sadi Konuk Eğitim Araştırma Hastanesi, İç Hastalıkları Kliniği, İstanbul, Türkiye Bakırköy Dr. Sadi Konuk Eğitim Araştırma Hastanesi, Tıbbi Onkoloji Bilim Dalı, İstanbul, Türkiye Objective: Breast cancer is the most common cancer in women. The incidence of bilateral breast cancer is 2%–11%. Synchronous bilateral breast cancer is uncommon (1%–2%). Bilateral breast cancer has worse prognosis than unilateral cancer. The aim of the retrospective study was to evaluate the incidence and demographic features of synchronous bilateral breast cancer patients in our hospital.Methods: We analyzed 266 breast cancer patients who were treated at our oncology department between January 2010 and December 2013. Five patients had synchronous bilateral breast cancer that was diagnosed at the same time.Results: We determined that five (1.87%) patients had synchronous bilateral breast cancer in this study. Of the five patients, one was a man and four were women. Median age was 53 years (40–64). Two patients were in premenopausal status. One patient revealed a positive family history of first-degree relatives. All of the patients had estrogen receptor positivity and invasive ductal carcinoma histopathology. Neoadjuvant chemotherapy was given to four patients. Only one metastatic patient had palliative chemotherapy. All patients had modified radical mastectomies and postoperative radiation therapy for bilateral breast cancer.Conclusion: Our clinical findings show a correlation with literature knowledge. Synchronous bilateral breast cancer is uncommon, and published data indicates worse prognosis. Hence, patients should be evaluated for the risk of contralateral breast cancer carefully at the same time of diagnosis. http://imj.galenos.com.tr/archives/archive-detail/article-preview/evaluation-of-patients-with-synchronous-bilateral-/20972 Synchronousbilateralbreast cancer
spellingShingle Elif Eda Tiken
Meral Günaldı
Yıldız Okuturlar
Savaş Tuna
Evaluation of Patients with Synchronous Bilateral Breast Cancer
İstanbul Medical Journal
Synchronous
bilateral
breast cancer
title Evaluation of Patients with Synchronous Bilateral Breast Cancer
title_full Evaluation of Patients with Synchronous Bilateral Breast Cancer
title_fullStr Evaluation of Patients with Synchronous Bilateral Breast Cancer
title_full_unstemmed Evaluation of Patients with Synchronous Bilateral Breast Cancer
title_short Evaluation of Patients with Synchronous Bilateral Breast Cancer
title_sort evaluation of patients with synchronous bilateral breast cancer
topic Synchronous
bilateral
breast cancer
url http://imj.galenos.com.tr/archives/archive-detail/article-preview/evaluation-of-patients-with-synchronous-bilateral-/20972
work_keys_str_mv AT elifedatiken evaluationofpatientswithsynchronousbilateralbreastcancer
AT meralgunaldı evaluationofpatientswithsynchronousbilateralbreastcancer
AT yıldızokuturlar evaluationofpatientswithsynchronousbilateralbreastcancer
AT savastuna evaluationofpatientswithsynchronousbilateralbreastcancer